SE0201726D0 - New method and composition - Google Patents
New method and compositionInfo
- Publication number
- SE0201726D0 SE0201726D0 SE0201726A SE0201726A SE0201726D0 SE 0201726 D0 SE0201726 D0 SE 0201726D0 SE 0201726 A SE0201726 A SE 0201726A SE 0201726 A SE0201726 A SE 0201726A SE 0201726 D0 SE0201726 D0 SE 0201726D0
- Authority
- SE
- Sweden
- Prior art keywords
- allogeneic
- antigen
- cellular
- pulsing
- apc
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201726A SE523515C2 (sv) | 2002-06-06 | 2002-06-06 | Ny metod och komposition för framställning av ett cellulärt allogent vaccin |
US10/516,915 US20050158328A1 (en) | 2002-06-06 | 2003-06-05 | Method and composition for producing a cellular allogeneic vaccine |
SI200332043T SI1509244T1 (sl) | 2002-06-06 | 2003-06-05 | Nov postopek in spojina za izdelavo celične alogenične vakcine |
EP03730977A EP1509244B1 (en) | 2002-06-06 | 2003-06-05 | New method and composition for producing a cellular allogeneic vaccine |
DK03730977.0T DK1509244T3 (da) | 2002-06-06 | 2003-06-05 | Ny fremgangsmåde og præparat til at producere en cellulær allogen vaccine |
ES03730977T ES2369077T3 (es) | 2002-06-06 | 2003-06-05 | Nuevo procedimiento y composición para producir una vacuna alogénica celular. |
AT03730977T ATE517633T1 (de) | 2002-06-06 | 2003-06-05 | Neues verfahren und zusammensetzung zur herstellung einer zellulären allogenen vakzine |
PCT/SE2003/000936 WO2003103707A1 (en) | 2002-06-06 | 2003-06-05 | New method and composition for producing a cellular allogeneic vaccine |
AU2003241252A AU2003241252A1 (en) | 2002-06-06 | 2003-06-05 | New method and composition for producing a cellular allogeneic vaccine |
US11/603,819 US8673296B2 (en) | 2002-06-06 | 2006-11-24 | Method and composition for producing a cellular allogeneic vaccine |
US14/164,518 US20140141046A1 (en) | 2002-06-06 | 2014-01-27 | Method and composition for producing a cellular allogeneic vaccine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201726A SE523515C2 (sv) | 2002-06-06 | 2002-06-06 | Ny metod och komposition för framställning av ett cellulärt allogent vaccin |
Publications (3)
Publication Number | Publication Date |
---|---|
SE0201726D0 true SE0201726D0 (sv) | 2002-06-06 |
SE0201726L SE0201726L (sv) | 2003-12-07 |
SE523515C2 SE523515C2 (sv) | 2004-04-27 |
Family
ID=20288098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0201726A SE523515C2 (sv) | 2002-06-06 | 2002-06-06 | Ny metod och komposition för framställning av ett cellulärt allogent vaccin |
Country Status (1)
Country | Link |
---|---|
SE (1) | SE523515C2 (sv) |
-
2002
- 2002-06-06 SE SE0201726A patent/SE523515C2/sv not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE0201726L (sv) | 2003-12-07 |
SE523515C2 (sv) | 2004-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50210575D1 (de) | In-vitro-verfahren zum herstellen einer homologen "gestenteten" tissue engineerten herzklappe | |
JP2019531744A5 (sv) | ||
IL248493A0 (en) | A method for increasing type 1 presentation of exogenous antigens using dendritic cells of human origin | |
WO2004096975A3 (en) | Apparatus and methods for amplification of blood stem cell numbers | |
WO2005007799A3 (en) | Methods for ex-vivo expanding stem/progenitor cells | |
DK1604016T3 (da) | In vitro-fremgangsmåde til differentiering af monocytiske dendritiske precursorceller i umodne dendritiske celler | |
MXPA02007137A (es) | Fuente de tejido hepatico. | |
DK1634949T3 (da) | Fremgangsmåde til at generere aktiverede T-celler og antigen-inkuberede antigen-præsenterende celler | |
MXPA05006042A (es) | Administracion de celulas dendriticas parcialmente maduradas in-vitro para el tratamiento de tumores. | |
HK1080111A1 (zh) | 為研究、臨床眼晴表面移植和組織工程的應用而生長人類結膜組織等同物的方法 | |
MXPA05006350A (es) | Composicion de medio de cultivo, procedimiento de cultivo y mioblastos obtenidos y sus utilizaciones. | |
US6703016B1 (en) | Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines | |
BR0211491A (pt) | Geração de células dendrìticas totalmente madura e estáveis de produtos de leucafereses para aplicações clìnicas | |
AU2003241252A1 (en) | New method and composition for producing a cellular allogeneic vaccine | |
ATE335808T1 (de) | Herstellung von zellsuspensionen | |
DK1699480T3 (da) | Allogent terapeutisk tumormiddel | |
DE60032508D1 (de) | VERFAHREN ZUR VERMEHRUNG VON NATüRLICHEN KILLERZELLEN | |
Westermann et al. | Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties | |
DK1419240T3 (da) | Fremstilling og anvendelse af humane CD124- og CD116-positive tumorcellelinier til fremstilling af allogene eller semi-allogene immumterapeutika | |
SE0201726D0 (sv) | New method and composition | |
CA2505527A1 (en) | Method for suppressing immune system response to transplanted tissue or cells | |
Chen et al. | Interleukin-10-induced T cell unresponsiveness can be reversed by dendritic cell stimulation | |
WO2002036748A3 (en) | Methods for depleting and isolating alloreactive and antigen-reactive t cells from hematopoietic donor cells | |
O'Connell et al. | Type‐1 polarized nature of mouse liver CD8α–and CD8α+ dendritic cells: tissue‐dependent differences offset CD8α‐related dendritic cell heterogeneity | |
US7429376B2 (en) | Methods of screening for compounds that improve engraftment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |